Literature DB >> 11355054

Chronic pain: treatment barriers and strategies for clinical practice.

M Glajchen1.   

Abstract

BACKGROUND: Chronic pain is a clinical challenge for the practicing physician. Lack of knowledge about opioids, negative attitudes toward prescribing opioids, and inadequate pain-assessment skills combine to create major barriers to pain relief. Patient-related barriers, such as lack of communication and unwarranted fears of addiction, further complicate pain assessment and treatment. The health care system itself can hinder pain relief through practical constraints in the community and fear of regulatory scrutiny by the physician.
METHODS: Information was gathered by doing a literature search, collating clinical information from practice and additional research findings from national meetings, and reviewing the Bulletin of the American Pain Society. Key search terms included "pain," "chronic pain," "pain management," "pain assessment," "pain treatment," and "barriers to pain management." RESULTS AND
CONCLUSIONS: Concrete steps for the clinician engaged in the treatment of chronic pain include selection and administration of an effective opioid, dose titration, short- vs long-acting opioids, opioid rotation, ongoing assessment, and consideration of patient preferences. In addition, communication, coping behaviors, and pain education play important roles in the pain equation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11355054

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  51 in total

1.  Chronic opioid therapy and preventive services in rural primary care: an Oregon rural practice-based research network study.

Authors:  David I Buckley; James F Calvert; Jodi A Lapidus; Cynthia D Morris
Journal:  Ann Fam Med       Date:  2010 May-Jun       Impact factor: 5.166

2.  Functional Limitation, Pain, and Alcohol Use: Exploring Gender Differences in the Mediating Role of Depressive Symptoms.

Authors:  Robyn Lewis Brown
Journal:  J Stud Alcohol Drugs       Date:  2015-09       Impact factor: 2.582

3.  Substance use disorders in a primary care sample receiving daily opioid therapy.

Authors:  Michael F Fleming; Stacey L Balousek; Cynthia L Klessig; Marlon P Mundt; David D Brown
Journal:  J Pain       Date:  2007-05-11       Impact factor: 5.820

4.  Morphine: friend or foe?

Authors:  Jane Bates; Liz Gwyther; Natalya Dinat
Journal:  Malawi Med J       Date:  2008-12       Impact factor: 0.875

Review 5.  A psychosocial approach to female genital pain.

Authors:  Marieke Dewitte; Charmaine Borg; Lior Lowenstein
Journal:  Nat Rev Urol       Date:  2017-11-28       Impact factor: 14.432

Review 6.  OROS hydromorphone prolonged release: a review of its use in the management of chronic, moderate to severe pain.

Authors:  Natalie J Carter; Gillian M Keating
Journal:  CNS Drugs       Date:  2010-04       Impact factor: 5.749

Review 7.  Recommendations for Substance Abuse and Pain Control in Patients with Chronic Pain.

Authors:  Nalini Vadivelu; Alice M Kai; Gopal Kodumudi; Dan Haddad; Vijay Kodumudi; Niketh Kuruvilla; Alan David Kaye; Richard D Urman
Journal:  Curr Pain Headache Rep       Date:  2018-03-19

8.  A comparative study of pain in heart failure and non-heart failure veterans.

Authors:  Joy R Goebel; Lynn V Doering; Lorraine S Evangelista; Adeline M Nyamathi; Sally L Maliski; Steven M Asch; Cathy D Sherbourne; Lisa R Shugarman; Andy B Lanto; Angela Cohen; Karl A Lorenz
Journal:  J Card Fail       Date:  2008-11-13       Impact factor: 5.712

9.  Designing an automated clinical decision support system to match clinical practice guidelines for opioid therapy for chronic pain.

Authors:  Jodie A Trafton; Susana B Martins; Martha C Michel; Dan Wang; Samson W Tu; David J Clark; Jan Elliott; Brigit Vucic; Steve Balt; Michael E Clark; Charles D Sintek; Jack Rosenberg; Denise Daniels; Mary K Goldstein
Journal:  Implement Sci       Date:  2010-04-12       Impact factor: 7.327

10.  Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic pain.

Authors:  A Sandner-Kiesling; P Leyendecker; M Hopp; L Tarau; J Lejcko; W Meissner; P Sevcik; M Hakl; R Hrib; R Uhl; H Dürr; K Reimer
Journal:  Int J Clin Pract       Date:  2010-03-29       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.